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centers need to have more actionable 
algorithms to monitor and decrease 
exposure to low dialysate potassium and 
calcium levels, and more diligence is 
needed on the part of clinicians regard-
ing monitoring and adjustment of the 
dialysate prescription. Finally, more in-
depth and mechanistic research is 
needed to evaluate potential SCA eti-
ologies whereby eff ective interventions 
can be developed to prevent SCA in 
hemodialysis patients. Mortality rates 
remain unconscionably high for dialysis 
patients, and we, the nephrology com-
munity, must do all that is possible to 
prevent this deadly outcome. 
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 Experimental acute kidney injury (AKI) 
is accompanied by the death of renal 
tubule epithelial cells, and the degree of 
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renal dysfunction correlates with the 
extent of injury. In ischemic and cispla-
tin-induced AKI, cells of the terminal 
portion of the proximal tubule, which 
are most prominently involved, undergo 
necrosis while scattered cells through-
out the nephron undergo apoptosis. 
How these cells die is the topic of active 
research, but recent focus has placed a 
major emphasis on the cells that medi-
ate innate and  adoptive immunity in the 
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 Experimental acute kidney injury (AKI) is accompanied by the death of 
renal tubule epithelial cells, necrosis and apoptosis of the terminal 
portion of the proximal tubule, and apoptosis in the distal nephron. 
While immune competent cells invading the kidney play a role in such 
cell death, intervention in these processes only partially ameliorates the 
extent of cell death. Given the results of Linkermann  et al. in this issue 
of  KI , an epithelium-derived component of immune mediated cell death 
must now be strongly considered. 
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induction of epithelial-cell death. 1 Th e 
major evidence for this focus derives 
from several observations. Th e fi rst of 
these stems from the inflammatory 
nature of the response to injury, includ-
ing that induced by cisplatin. 2 Interven-
tion in these processes, by either genetic 
manipulations or inhibition of activated 
immune participants, has had a salutary, 
albeit partial, effect on the resultant 
AKI. An epithelial-derived component 
of immune-mediated cell death has 
been neglected. 
 It has long been known that morpho-
logically intact epithelial cells express 
chemokines and cytokines more usually 
associated with leukocytes, suggesting 
that such cells might act as the source of 
infl ammatory signals. 2 More recently, 
chimeras of Toll-like receptor 4 (TLR4)-
defi cient mice show that the epithelial-
cell expression of TLR4, and not that 
associated with myeloid cells that invade 
the kidney, plays a dominant role in the 
increased cell death, reduced function, 
and infl ammatory state that character-
ize cisplatin AKI. 3 Th ese observations, 
coupled with the close juxtaposition of 
the relevant cells ( Figure 1 ), make it 
highly likely that cell-death signals can 
emerge from neighboring cells. Until 
now, 4 the possibility of an epithelial-
derived form of fratricide, or the killing 
of brother or sister cells that is much 
more typical of T cells, 5 has been a 
source of speculation only. 
 Linkermann  et al. 4 (this issue) now pro-
vide unequivocal proof that epithelial-
derived fratricide occurs in the kidney. 
It was known that the Fas ligand (FasL) 
and its receptor Fas, members of the 
tumor necrosis factor family of death 
receptors that execute fratricide in lym-
phocytes, were upregulated in kidney epi-
thelial cells during cisplatin-induced AKI 
and that inhibition of this system led to 
protection. 6 What remained unanswered 
was the precise role of this epithelial-
derived system in induction of cell death. 
Using animals without T cells and natural 
killer cells, Linkermann  et al. 4 found that 
cisplatin induced as severe AKI in such 
immune-defi cient animals as it did in ani-
mals with a normal complement of these 
cells. Only aft er the addition of an anti-
body against FasL to such immune-
incompetent animals was protection both 
functionally and histologically achieved. 
Th e fi nal proof of fratricide was demon-
strated elegantly  in vitro , where freshly 
isolated proximal tubules previously 
exposed to cisplatin  in vitro execute apop-
tosis in coculture with similarly isolated 
thick ascending limbs. Here again induc-
tion of apoptosis was inhibited by a neu-
tralizing antibody against FasL. 
 Th ese experiments resolve some of the 
long-standing debates about the execu-
tioners of cell death in AKI but raise new 
questions. It would appear that the partial 
inhibition of AKI using strategies directed 
at myeloid cells now has an adequate 
explanation. But beyond that demonstra-
tion is the tantalizing prospect that the 
epithelial cells may communicate with 
one another on other issues of cell fate. 
Administration of the anti-FasL antibody 
 in vivo reduced necrosis, an event 
restricted to the proximal tubule  in vivo , 
as well as apoptosis, a result more typical 
of the response in the distal nephron in 
cisplatin-induced AKI. Th is suggests that 
information transfer in these cell types 
may proceed in both directions. Th e epi-
thelial compartment of the kidneys of 
animals exposed to cisplatin is an active 
participant in a full range of molecular 
events, most prominently in cells that are 
not destined to die, including the thick 
ascending limb. 7 Th e possibility that such 
surviving cells communicate with their 
neighbors ( Figure 1 ), or at a distance 
through the luminal fl uid or via the peri-
tubular blood, to serve other functions 
besides fratricide must now be consid-
ered. By demonstrating this ability of the 
proximal tubule under stress to aff ect the 
cell fate of a neighboring cell should bring 
renewed focus on the abilities of the epi-
thelial compartment to initiate signals 
that are determinant of the syndrome of 
AKI, including regeneration and recov-
ery. Th e demonstration of the cross-talk 
capabilities of the stressed proximal 
tubule by Linkermann and his colleagues 4 
should foster a search for the proper spa-
tiotemporal changes in gene expression 
that more fully explain the syndrome of 
AKI. Th ese studies should usher in a more 
tubulocentric approach to issues of cell 
fate during AKI. 
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 Figure 1  |  Section of outer strip of inner medulla from a rat injected with cisplatin 3 days 
before. Note necrotic remnants of proximal straight tubule in close apposition with surviving 
thick ascending limb cells. CD, collecting duct; ND, necrotic debris; PT, proximal tubule; TAL, thick 
ascending limb. 
